 | • レポートコード：GIR-107A14397 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アプレピタントのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アプレピタントの種類別市場規模（注射、経口）、用途別市場規模（病院、ドラッグストア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アプレピタントの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck & Co.、Heron Therapeutics、Sandoz、Glenmark Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：注射、経口 ・用途別分析2016年-2026年：病院、ドラッグストア ・アプレピタントの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アプレピタントのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アプレピタントのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アプレピタントの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アプレピタントの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Aprepitant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Aprepitant size is estimated to be xx million in 2021 from USD XX million in 2020, with a change of XX% between 2020 and 2021. The global Aprepitant market size is expected to grow at a CAGR of XX% for the next five years.
Market segmentation
Aprepitant market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Injection
Oral
Market segment by Application can be divided into
Hospital
Drug store
The key market players for global Aprepitant market are listed below:
Merck & Co.
Heron Therapeutics
Sandoz
Glenmark Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Aprepitant product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Aprepitant, with price, sales, revenue and global market share of Aprepitant in 2018 and 2019.
Chapter 3, the Aprepitant competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aprepitant breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Aprepitant market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Aprepitant sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Aprepitant Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Aprepitant Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Injection
1.2.3 Oral
1.3 Market Analysis by Application
1.3.1 Overview: Global Aprepitant Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Aprepitant Market Size & Forecast
1.4.1 Global Aprepitant Sales in Value (2016-2026))
1.4.2 Global Aprepitant Sales in Volume (2016-2026)
1.4.3 Global Aprepitant Price by Type (2016-2026) & (USD/Unit)
1.5 Global Aprepitant Production Capacity Analysis
1.5.1 Global Aprepitant Total Production Capacity (2016-2026)
1.5.2 Global Aprepitant Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Aprepitant Market Drivers
1.6.2 Aprepitant Market Restraints
1.6.3 Aprepitant Trends Analysis
2 Manufacturers Profiles
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Aprepitant Product and Services
2.1.4 Merck & Co. Aprepitant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Heron Therapeutics
2.2.1 Heron Therapeutics Details
2.2.2 Heron Therapeutics Major Business
2.2.3 Heron Therapeutics Aprepitant Product and Services
2.2.4 Heron Therapeutics Aprepitant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Sandoz
2.3.1 Sandoz Details
2.3.2 Sandoz Major Business
2.3.3 Sandoz Aprepitant Product and Services
2.3.4 Sandoz Aprepitant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Glenmark Pharmaceuticals
2.4.1 Glenmark Pharmaceuticals Details
2.4.2 Glenmark Pharmaceuticals Major Business
2.4.3 Glenmark Pharmaceuticals Aprepitant Product and Services
2.4.4 Glenmark Pharmaceuticals Aprepitant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Aprepitant Sales by Manufacturer
3.1 Global Aprepitant Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Aprepitant Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Aprepitant
3.4 Market Concentration Rate
3.4.1 Top 3 Aprepitant Manufacturer Market Share
3.4.2 Top 6 Aprepitant Manufacturer Market Share
3.5 Global Aprepitant Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Aprepitant Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Aprepitant Market Size by Region
4.1.1 Global Aprepitant Sales in Volume by Region (2016-2026)
4.1.2 Global Aprepitant Revenue by Region (2016-2026)
4.2 North America Aprepitant Revenue (2016-2026)
4.3 Europe Aprepitant Revenue (2016-2026)
4.4 Asia-Pacific Aprepitant Revenue (2016-2026)
4.5 South America Aprepitant Revenue (2016-2026)
4.6 Middle East and Africa Aprepitant Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Aprepitant Sales in Volume by Type (2016-2026)
5.2 Global Aprepitant Revenue by Type (2016-2026)
5.3 Global Aprepitant Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Aprepitant Sales in Volume by Application (2016-2026)
6.2 Global Aprepitant Revenue by Application (2016-2026)
6.3 Global Aprepitant Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Aprepitant Sales by Type (2016-2026)
7.2 North America Aprepitant Sales by Application (2016-2026)
7.3 North America Aprepitant Market Size by Country
7.3.1 North America Aprepitant Sales in Volume by Country (2016-2026)
7.3.2 North America Aprepitant Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Aprepitant Sales by Type (2016-2026)
8.2 Europe Aprepitant Sales by Application (2016-2026)
8.3 Europe Aprepitant Market Size by Country
8.3.1 Europe Aprepitant Sales in Volume by Country (2016-2026)
8.3.2 Europe Aprepitant Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Aprepitant Sales by Type (2016-2026)
9.2 Asia-Pacific Aprepitant Sales by Application (2016-2026)
9.3 Asia-Pacific Aprepitant Market Size by Region
9.3.1 Asia-Pacific Aprepitant Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Aprepitant Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Aprepitant Sales by Type (2016-2026)
10.2 South America Aprepitant Sales by Application (2016-2026)
10.3 South America Aprepitant Market Size by Country
10.3.1 South America Aprepitant Sales in Volume by Country (2016-2026)
10.3.2 South America Aprepitant Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Aprepitant Sales by Type (2016-2026)
11.2 Middle East & Africa Aprepitant Sales by Application (2016-2026)
11.3 Middle East & Africa Aprepitant Market Size by Country
11.3.1 Middle East & Africa Aprepitant Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Aprepitant Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Aprepitant Typical Distributors
12.3 Aprepitant Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Aprepitant Revenue by Type, (USD Million), 2021-2026
Table 2. Global Aprepitant Revenue by Application, (USD Million), 2021-2026
Table 3. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co. Major Business
Table 5. Merck & Co. Aprepitant Product and Services
Table 6. Merck & Co. Aprepitant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Heron Therapeutics Basic Information, Manufacturing Base and Competitors
Table 8. Heron Therapeutics Major Business
Table 9. Heron Therapeutics Aprepitant Product and Services
Table 10. Heron Therapeutics Aprepitant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sandoz Basic Information, Manufacturing Base and Competitors
Table 12. Sandoz Major Business
Table 13. Sandoz Aprepitant Product and Services
Table 14. Sandoz Aprepitant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Glenmark Pharmaceuticals Major Business
Table 17. Glenmark Pharmaceuticals Aprepitant Product and Services
Table 18. Glenmark Pharmaceuticals Aprepitant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Aprepitant Sales by Manufacturer (2019-2021e) & (K Units)
Table 20. Global Aprepitant Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Aprepitant, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Aprepitant Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Aprepitant Production Site of Key Manufacturer
Table 24. Aprepitant New Entrant and Capacity Expansion Plans
Table 25. Aprepitant Mergers & Acquisitions in the Past Five Years
Table 26. Global Aprepitant Sales by Region (2016-2021e) & (K Units)
Table 27. Global Aprepitant Sales by Region (2021-2026) & (K Units)
Table 28. Global Aprepitant Revenue by Region (2016-2021e) & (USD Million)
Table 29. Global Aprepitant Revenue by Region (2021-2026) & (USD Million)
Table 30. Global Aprepitant Sales by Type (2016-2021e) & (K Units)
Table 31. Global Aprepitant Sales by Type (2021-2026) & (K Units)
Table 32. Global Aprepitant Revenue by Type (2016-2021e) & (USD Million)
Table 33. Global Aprepitant Revenue by Type (2021-2026) & (USD Million)
Table 34. Global Aprepitant Price by Type (2016-2021e) & (USD/Unit)
Table 35. Global Aprepitant Price by Type (2021-2026) & (USD/Unit)
Table 36. Global Aprepitant Sales by Application (2016-2021e) & (K Units)
Table 37. Global Aprepitant Sales by Application (2021-2026) & (K Units)
Table 38. Global Aprepitant Revenue by Application (2016-2021e) & (USD Million)
Table 39. Global Aprepitant Revenue by Application (2021-2026) & (USD Million)
Table 40. Global Aprepitant Price by Application (2016-2021e) & (USD/Unit)
Table 41. Global Aprepitant Price by Application (2021-2026) & (USD/Unit)
Table 42. North America Aprepitant Sales by Country (2016-2021e) & (K Units)
Table 43. North America Aprepitant Sales by Country (2021-2026) & (K Units)
Table 44. North America Aprepitant Revenue by Country (2016-2021e) & (USD Million)
Table 45. North America Aprepitant Revenue by Country (2021-2026) & (USD Million)
Table 46. North America Aprepitant Sales by Type (2016-2021e) & (K Units)
Table 47. North America Aprepitant Sales by Type (2021-2026) & (K Units)
Table 48. North America Aprepitant Sales by Application (2016-2021e) & (K Units)
Table 49. North America Aprepitant Sales by Application (2021-2026) & (K Units)
Table 50. Europe Aprepitant Sales by Country (2016-2021e) & (K Units)
Table 51. Europe Aprepitant Sales by Country (2021-2026) & (K Units)
Table 52. Europe Aprepitant Revenue by Country (2016-2021e) & (USD Million)
Table 53. Europe Aprepitant Revenue by Country (2021-2026) & (USD Million)
Table 54. Europe Aprepitant Sales by Type (2016-2021e) & (K Units)
Table 55. Europe Aprepitant Sales by Type (2021-2026) & (K Units)
Table 56. Europe Aprepitant Sales by Application (2016-2021e) & (K Units)
Table 57. Europe Aprepitant Sales by Application (2021-2026) & (K Units)
Table 58. Asia-Pacific Aprepitant Sales by Region (2016-2021e) & (K Units)
Table 59. Asia-Pacific Aprepitant Sales by Region (2021-2026) & (K Units)
Table 60. Asia-Pacific Aprepitant Revenue by Region (2016-2021e) & (USD Million)
Table 61. Asia-Pacific Aprepitant Revenue by Region (2021-2026) & (USD Million)
Table 62. Asia-Pacific Aprepitant Sales by Type (2016-2021e) & (K Units)
Table 63. Asia-Pacific Aprepitant Sales by Type (2021-2026) & (K Units)
Table 64. Asia-Pacific Aprepitant Sales by Application (2016-2021e) & (K Units)
Table 65. Asia-Pacific Aprepitant Sales by Application (2021-2026) & (K Units)
Table 66. South America Aprepitant Sales by Country (2016-2021e) & (K Units)
Table 67. South America Aprepitant Sales by Country (2021-2026) & (K Units)
Table 68. South America Aprepitant Revenue by Country (2016-2021e) & (USD Million)
Table 69. South America Aprepitant Revenue by Country (2021-2026) & (USD Million)
Table 70. South America Aprepitant Sales by Type (2016-2021e) & (K Units)
Table 71. South America Aprepitant Sales by Type (2021-2026) & (K Units)
Table 72. South America Aprepitant Sales by Application (2016-2021e) & (K Units)
Table 73. South America Aprepitant Sales by Application (2021-2026) & (K Units)
Table 74. Middle East & Africa Aprepitant Sales by Country (2016-2021e) & (K Units)
Table 75. Middle East & Africa Aprepitant Sales by Country (2021-2026) & (K Units)
Table 76. Middle East & Africa Aprepitant Revenue by Country (2016-2021e) & (USD Million)
Table 77. Middle East & Africa Aprepitant Revenue by Country (2021-2026) & (USD Million)
Table 78. Middle East & Africa Aprepitant Sales by Type (2016-2021e) & (K Units)
Table 79. Middle East & Africa Aprepitant Sales by Type (2021-2026) & (K Units)
Table 80. Middle East & Africa Aprepitant Sales by Application (2016-2021e) & (K Units)
Table 81. Middle East & Africa Aprepitant Sales by Application (2021-2026) & (K Units)
Table 82. Direct Channel Pros & Cons
Table 83. Indirect Channel Pros & Cons
Table 84. Aprepitant Typical Distributors
Table 85. Aprepitant Typical Customers
List of Figures
Figure 1. Aprepitant Picture
Figure 2. Global Aprepitant Sales Market Share by Type in 2020
Figure 3. Injection
Figure 4. Oral
Figure 5. Global Aprepitant Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Drug store
Figure 8. Global Aprepitant Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Aprepitant Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Aprepitant Sales (2016-2026) & (K Units)
Figure 11. Global Aprepitant Price by Type (2016-2026) & (USD/Unit)
Figure 12. Global Aprepitant Production Capacity (2016-2026) & (K Units)
Figure 13. Global Aprepitant Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Aprepitant Market Drivers
Figure 15. Aprepitant Market Restraints
Figure 16. Aprepitant Market Trends
Figure 17. Global Aprepitant Sales Market Share by Manufacturer in 2020
Figure 18. Global Aprepitant Revenue Market Share by Manufacturer in 2020
Figure 19. Aprepitant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Aprepitant Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Aprepitant Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Aprepitant Sales Market Share by Region (2016-2026)
Figure 23. Global Aprepitant Revenue Market Share by Region (2016-2026)
Figure 24. North America Aprepitant Revenue (2016-2026) & (USD Million)
Figure 25. Europe Aprepitant Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Aprepitant Revenue (2016-2026) & (USD Million)
Figure 27. South America Aprepitant Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Aprepitant Revenue (2016-2026) & (USD Million)
Figure 29. Global Aprepitant Sales Market Share by Type (2016-2026)
Figure 30. Global Aprepitant Revenue Market Share by Type (2016-2026)
Figure 31. Global Aprepitant Price by Type (2016-2026) & (USD/Unit)
Figure 32. Global Aprepitant Sales Market Share by Application (2016-2026)
Figure 33. Global Aprepitant Revenue Market Share by Application (2016-2026)
Figure 34. Global Aprepitant Price by Application (2016-2026) & (USD/Unit)
Figure 35. North America Aprepitant Sales Market Share by Type (2016-2026)
Figure 36. North America Aprepitant Sales Market Share by Application (2016-2026)
Figure 37. North America Aprepitant Sales Market Share by Country (2016-2026)
Figure 38. North America Aprepitant Revenue Market Share by Country (2016-2026)
Figure 39. United States Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Aprepitant Sales Market Share by Type (2016-2026)
Figure 43. Europe Aprepitant Sales Market Share by Application (2016-2026)
Figure 44. Europe Aprepitant Sales Market Share by Country (2016-2026)
Figure 45. Europe Aprepitant Revenue Market Share by Country (2016-2026)
Figure 46. Germany Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Aprepitant Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Aprepitant Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Aprepitant Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Aprepitant Revenue Market Share by Region (2016-2026)
Figure 55. China Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Aprepitant Sales Market Share by Type (2016-2026)
Figure 62. South America Aprepitant Sales Market Share by Application (2016-2026)
Figure 63. South America Aprepitant Sales Market Share by Country (2016-2026)
Figure 64. South America Aprepitant Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Aprepitant Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Aprepitant Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Aprepitant Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Aprepitant Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Aprepitant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の経口徐放性ドラッグデリバリー技術市場 2021：企業別、地域別、種類・用途別 The Oral Controlled Release Drug Delivery Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…- 世界のビンポセチン注射市場 2021：企業別、地域別、種類・用途別 The Vinpocetine Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界のオキシラセタム注射市場 2021：企業別、地域別、種類・用途別 The Oxiracetam Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界のタダラフィル経口薬市場 2021：企業別、地域別、種類・用途別 The Tadalafil Oral market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界のアンブリセンタン薬市場 2021：企業別、地域別、種類・用途別 The Ambrisentan Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…